ACB Aurora Cannabis, Inc.: יחס שווי שוק לערך בספרים

The Aurora Cannabis (ACB) price chart reflects the dynamics of a company that has shifted its strategic focus from mass retail to profitable B2B medical supplies for Australia and the European Union. The current figure is 0.71. The business relies on a closed-loop production cycle and global logistics for pharmacy chains; however, growth is constrained by strict oversight from ministries of health and difficulties in securing export quotas.

Aurora Cannabis is scaling its medical cannabis production while facing high greenhouse maintenance costs and regulatory barriers. This relative market capital valuation metric compares the company's market value to its net assets, determining the business's maturity level and the risk of overvaluation when quotes move beyond the historical median during periods of tight monetary policy.